Assignee
MITSUBISHI TANABE PHARMA CORP
JP·158 granted patents·82 pending applications·676 citations·filing 2000–2025
Top patents by PatentIndex Score
240 records- 0196US11241416B2Edaravone suspension for oral administrationMITSUBISHI TANABE PHARMA CORP·Filed 2021·Granted Feb 8, 2022·9 cites·20 claims
- 0296US10987341B2Edaravone suspension for oral administrationMITSUBISHI TANABE PHARMA CORP·Filed 2020·Granted Apr 27, 2021·11 cites·25 claims
- 0394US11478450B2Edaravone suspension for oral administrationMITSUBISHI TANABE PHARMA CORP·Filed 2021·Granted Oct 25, 2022·5 cites·20 claims
- 0494US9125915B2Antitumor agentMITSUBISHI TANABE PHARMA CORP·Filed 2013·Granted Sep 8, 2015·60 cites·6 claims
- 0594US7943582B2Crystalline form of 1-(β-D-glucopyransoyl)-4-methyl-3-[5-(4-fluorophenyl)-2- thienylmethyl]benzene hemihydrateMITSUBISHI TANABE PHARMA CORP·Filed 2007·Granted May 17, 2011·31 cites·7 claims
- 0693US11957660B2Edaravone suspension for oral administrationMITSUBISHI TANABE PHARMA CORP·Filed 2022·Granted Apr 16, 2024·2 cites·20 claims
- 0793US8044019B2Cell penetrating peptideMITSUBISHI TANABE PHARMA CORP·Filed 2006·Granted Oct 25, 2011·67 cites·31 claims
- 0893US7943788B2Glucopyranoside compoundMITSUBISHI TANABE PHARMA CORP·Filed 2005·Granted May 17, 2011·36 cites·26 claims
- 0993US7872006B2Pyrazole compounds having cannabinoid receptor (CB1) antagonizing activityMITSUBISHI TANABE PHARMA CORP·Filed 2006·Granted Jan 18, 2011·29 cites·7 claims
- 1092US11826352B2Edaravone suspension for oral administrationMITSUBISHI TANABE PHARMA CORP·Filed 2021·Granted Nov 28, 2023·2 cites·24 claims
- 1192US8044042B2Thienotriazolodiazepine compound and medicinal use thereofMITSUBISHI TANABE PHARMA CORP·Filed 2006·Granted Oct 25, 2011·49 cites·31 claims
- 1291US12194025B2Pharmaceutical composition for oral administration of edaravone and method of administering sameMITSUBISHI TANABE PHARMA CORP·Filed 2023·Granted Jan 14, 2025·4 cites·27 claims
- 1391US9758578B2Human anti-IL-33 neutralizing monoclonal antibodyMITSUBISHI TANABE PHARMA CORP·Filed 2014·Granted Sep 12, 2017·15 cites·20 claims
- 1491US7666869B2Nitrogen-containing 5-membered ring compoundMITSUBISHI TANABE PHARMA CORP·Filed 2007·Granted Feb 23, 2010·7 cites·2 claims
- 1590US12310946B2Pharmaceutical composition for oral administration of edaravone and method of administering sameMITSUBISHI TANABE PHARMA CORP·Filed 2024·Granted May 27, 2025·2 cites·20 claims
- 1690US8003669B2Remedy for sleep disturbanceMITSUBISHI TANABE PHARMA CORP·Filed 2009·Granted Aug 23, 2011·16 cites·9 claims
- 1790US7323039B2Method for preparing microsphereMITSUBISHI TANABE PHARMA CORP·Filed 2005·Granted Jan 29, 2008·9 cites·11 claims
- 1889US11890288B2Sulfonamide or sulfinamide compound having effect of inducing BRD4 protein degradation and pharmaceutical use thereofMITSUBISHI TANABE PHARMA CORP·Filed 2023·Granted Feb 6, 2024·2 cites·11 claims
- 1989US9981960B2Pyrrolidine compound and application as melanocortin receptor agonistMITSUBISHI TANABE PHARMA CORP·Filed 2015·Granted May 29, 2018·9 cites·33 claims
- 2089US7872126B2Tetrahydroquinoline derivatives and a process for preparing the sameMITSUBISHI TANABE PHARMA CORP·Filed 2006·Granted Jan 18, 2011·32 cites·11 claims
- 2189US7488591B2Process for producing protein with reduction of acidic sugar chain and glycoprotein produced therebyMITSUBISHI TANABE PHARMA CORP·Filed 2007·Granted Feb 10, 2009·12 cites·2 claims
- 2288US11740219B2Analysis method of 3-methyl-1-phenyl-2-pyrazolin-5-one active pharmaceutical ingredient, treatment for amyotrophic lateral sclerosis, inhibition of progression of amyotrophic lateral sclerosis, and method of producing medicament containing 3-methyl-1-phenyl-2-pyrazolin-5-one active pharmaceutical ingredientMITSUBISHI TANABE PHARMA CORP·Filed 2022·Granted Aug 29, 2023·3 cites·6 claims
- 2388US7994315B2Intermediate compound for synthesizing pharmaceutical agent and production method thereofMITSUBISHI TANABE PHARMA CORP·Filed 2006·Granted Aug 9, 2011·5 cites·2 claims
- 2486US11008388B2RGMa binding protein and use thereofMITSUBISHI TANABE PHARMA CORP·Filed 2019·Granted May 18, 2021·3 cites·17 claims
- 2586US8003790B2Salt of proline derivative, solvate thereof, and production method thereofMITSUBISHI TANABE PHARMA CORP·Filed 2006·Granted Aug 23, 2011·13 cites·8 claims
- 2685US7566728B2Remedy for sleep disturbanceMITSUBISHI TANABE PHARMA CORP·Filed 2003·Granted Jul 28, 2009·17 cites·5 claims
- 2785US2026048038A1Pharmaceutical composition for oral administration of edaravone and method of administering sameMITSUBISHI TANABE PHARMA CORP·Filed 2025·Application pending·0 cites
- 2884US12516114B2Human anti-IL-33 neutralizing monoclonal antibodyMITSUBISHI TANABE PHARMA CORP·Filed 2023·Granted Jan 6, 2026·0 cites·3 claims
- 2984US12320793B2Analysis method of 3-methyl-1-phenyl-2-pyrazolin-5-one active pharmaceutical ingredient, treatment for amyotrophic lateral sclerosis, inhibition of progression of amyotrophic lateral sclerosis, and method of producing medicament containing 3-methyl-1-phenyl-2-pyrazolin-5-one active pharmaceutical ingredientMITSUBISHI TANABE PHARMA CORP·Filed 2023·Granted Jun 3, 2025·1 cites·20 claims
- 3084US10029993B2Disubstituted 1, 2, 4-triazine compoundMITSUBISHI TANABE PHARMA CORP·Filed 2015·Granted Jul 24, 2018·4 cites·16 claims
- 3184US8354401B2Oxazolidinone amide aromatic compounds for supressing MMP-9 productionMITSUBISHI TANABE PHARMA CORP·Filed 2009·Granted Jan 15, 2013·10 cites·14 claims
- 3283US12527769B2Pharmaceutical composition for oral administration of edaravone and method of administering sameMITSUBISHI TANABE PHARMA CORP·Filed 2024·Granted Jan 20, 2026·0 cites·20 claims
- 3383US7935674B2Indole derivativesMITSUBISHI TANABE PHARMA CORP·Filed 2009·Granted May 3, 2011·3 cites·19 claims
- 3482US10323095B2Antibody-fynomer conjugatesMITSUBISHI TANABE PHARMA CORP·Filed 2015·Granted Jun 18, 2019·7 cites·20 claims
- 3582US10287346B2RGMa binding protein and use thereofMITSUBISHI TANABE PHARMA CORP·Filed 2016·Granted May 14, 2019·4 cites·14 claims
- 3682US8362274B2Arylalkylamine compound and process for preparing the sameMITSUBISHI TANABE PHARMA CORP·Filed 2005·Granted Jan 29, 2013·6 cites·11 claims
- 3782US7906517B2Trisubstituted amine compoundMITSUBISHI TANABE PHARMA CORP·Filed 2008·Granted Mar 15, 2011·6 cites·18 claims
- 3881US12285409B2Edaravone suspension for oral administrationMITSUBISHI TANABE PHARMA CORP·Filed 2023·Granted Apr 29, 2025·0 cites·20 claims
- 3981US7572793B23-Substituted-4-pyrimidone derivativesMITSUBISHI TANABE PHARMA CORP·Filed 2002·Granted Aug 11, 2009·20 cites·23 claims
- 4080US11285160B2Pharmaceutical composition and method for treatment of non-alcoholic fatty liver diseaseMITSUBISHI TANABE PHARMA CORP·Filed 2017·Granted Mar 29, 2022·2 cites·20 claims
- 4180US7718703B2Norvaline derivative and method for preparation thereofMITSUBISHI TANABE PHARMA CORP·Filed 2006·Granted May 18, 2010·5 cites·13 claims
- 4280US7531537B2Benzofuran derivativeMITSUBISHI TANABE PHARMA CORP·Filed 2003·Granted May 12, 2009·11 cites·17 claims
- 4379US11958812B23, 5-disubstituted pyridine and 3, 5-disubstituted pyridazine derivatives and pharmaceutical use of sameMITSUBISHI TANABE PHARMA CORP·Filed 2019·Granted Apr 16, 2024·2 cites·12 claims
- 4479US10993939B2Compositions for treating or preventing vasomotor symptomsMITSUBISHI TANABE PHARMA CORP·Filed 2017·Granted May 4, 2021·1 cites·18 claims
- 4579US7989627B2Optically active cyclic alcohol compound and method for preparing the sameMITSUBISHI TANABE PHARMA CORP·Filed 2006·Granted Aug 2, 2011·3 cites·1 claims
- 4679US7851617B2Indole derivativesMITSUBISHI TANABE PHARMA CORP·Filed 2007·Granted Dec 14, 2010·6 cites·12 claims
- 4778US7759373B2Large conductance calcium-activated K channel openerMITSUBISHI TANABE PHARMA CORP·Filed 2002·Granted Jul 20, 2010·16 cites·4 claims
- 4877US11104662B2Method for producing optically active pyrrolidine compoundsMITSUBISHI TANABE PHARMA CORP·Filed 2018·Granted Aug 31, 2021·2 cites·17 claims
- 4977US7514439B2Oxime derivative and preparations thereofMITSUBISHI TANABE PHARMA CORP·Filed 2006·Granted Apr 7, 2009·6 cites·3 claims
- 5077US7501412B2Isoquinoline compounds and medicinal use thereofMITSUBISHI TANABE PHARMA CORP·Filed 2003·Granted Mar 10, 2009·9 cites·24 claims
Showing the top 50 of 240 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when MITSUBISHI TANABE PHARMA CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →